Incidence of symptomatic, image-confirmed venous thromboembolism following hospitalization for COVID-19 with 90-day follow-up90일 추적 관찰과 함께 COVID-19로 입원한 후 증상이 있는 영상 확인 정맥 혈전 색전증의 발생률Article Published on 2020-12-222022-09-11 Journal: Blood advances [Category] SARS, 바이오마커, [키워드] 24 hour 24 hours Admission anticoagulation bleeding Care caution collected COVID-19 death discharge discharged event Follow-up heparin highlighting hospital Hospitalization indication invasive ventilation level of care low molecular weight low molecular weight heparin Lung imaging major bleeding majority medical record medical records National Noninvasive ventilation Observational data occurred on admission Patient patients presenting Prevention strategy Randomized controlled trial receive receiving reported retrospective risk standard thromboprophylaxis subsegmental symptomatic therapeutic anticoagulation Thromboprophylaxis thrombosis Treatment Venous Thromboembolism VTE ward were excluded [DOI] 10.1182/bloodadvances.2020003349 PMC 바로가기 [Article Type] Article
Intermediate versus standard-dose prophylactic anticoagulation and statin therapy versus placebo in critically-ill patients with COVID-19: Rationale and design of the INSPIRATION/INSPIRATION-S studiesCOVID-19 중증 환자에서 중간 용량 대 표준 용량 예방적 항응고제 및 스타틴 요법 대 위약: INSPIRATION/INSPIRATION-S 연구의 이론적 근거 및 설계Article Published on 2020-12-012022-09-11 Journal: Thrombosis research [Category] 임상, [키워드] all-cause mortality Analysis anticoagulation antithrombotic therapy Arterial thrombosis atorvastatin bleeding Chain Reaction cohorts Composite Controlled trial coronavirus disease Coronavirus disease 2019 COVID-19 death double-blind eligibility criteria Enrollment Exploratory analyses Exploratory analysis extracorporeal membrane oxygenation factorial design hallmark hallmarks help hypothese Hypothesis immune response include independent inferiority inspiration intensity intention-to-treat intermediate limit liver enzyme liver enzymes major bleeding management manifestation matching placebo modified intention-to-treat Myopathy non-inferiority non-inferiority margin normal limit Odds ratio open open label Patient patients with COVID-19 per-protocol performed Placebo Platelet Platelet count polymerase chain polymerase chain reaction Prevent primary endpoint Prophylactic prophylactic anticoagulation question randomization Randomized Randomized controlled trial rationale Result reverse transcription reverse transcription polymerase chain reaction safety endpoint screened secondary endpoint Standard dose Standard-dose statin Stratified randomization subgroup tested therapy thrombocytopenia thrombosis thrombotic event Thrombotic events undergo Venous Thromboembolism Ventilator-free days VTE [DOI] 10.1016/j.thromres.2020.09.027 PMC 바로가기 [Article Type] Article
Venous Thromboembolism in COVID-19COVID-19의 정맥 혈전색전증Review Published on 2020-12-012022-09-11 Journal: Thrombosis and haemostasis [Category] MERS, SARS, 바이오마커, [키워드] Biomarkers Characteristics Chemoprophylaxis coronavirus disease Coronavirus disease 2019 COVID-19 dose Evidence flu general treatment Guidance H1N1 hematological ill patient mechanism pandemic Pathogenesis patients with COVID-19 Prophylaxis Pulmonary embolism recommendation risk Risk assessment risk factor swine flu Thromboinflammation Treatment Venous Thromboembolism VTE [DOI] 10.1055/s-0040-1718532 PMC 바로가기 [Article Type] Review
Biomarkers for the prediction of venous thromboembolism in critically ill COVID-19 patients중환자 코로나19 환자의 정맥 혈전색전증 예측을 위한 바이오마커Article Published on 2020-12-012022-09-11 Journal: Thrombosis research [Category] MERS, SARS, 바이오마커, [키워드] activated activated partial thromboplastin time an area Analysis Antithrombin AUC Biomarker C-reactive protein characteristic clinician Combination Computed tomography computed tomography scan Confirmed COVID-19 infection coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 infection COVID-19 patient COVID-19 patients Critical illness Critically ill critically ill COVID-19 patients Critically ill patient critically ill patients CRP D-dimer develop diagnosed Diagnosis dimer early diagnosis End Expiratory Pressure fibrinogen hospital Hypoxemia intensive care intensive care unit International international normalized ratio Linear regression Mortality Multivariate analysis Negative predictive value normalized PaO partial thromboplastin time Patient Platelet Platelet count Positive End Expiratory Pressure Positive predictive value predicted Predictive Predictive value pressure Probability receiver operating characteristic retrospective cohort study risk ROC ROC Curve the timing Thromboembolism THROMBOPLASTIN Treatment Ultrasound variable Venous Thromboembolism VTE was done were used [DOI] 10.1016/j.thromres.2020.09.017 PMC 바로가기 [Article Type] Article
Evaluation of the prothrombin fragment 1.2 in patients with coronavirus disease 2019 (COVID-19)코로나바이러스 질환 2019(COVID-19) 환자의 프로트롬빈 단편 1.2 평가Article Published on 2020-12-012022-09-11 Journal: American journal of hematology [Category] MERS, SARS, 바이오마커, [키워드] 95% CI Activation adjusted adjusted odds ratio Analysis association characteristic Coagulation coronavirus disease Coronavirus disease 2019 COVID-19 Critically ill D-dimer described develop diagnosing dimer elevated Elevation evaluate evaluated Hospitalization Hospitalized hospitalized patient hospitalized patients hypercoagulable Hypercoagulable state Laboratory likelihood ratio manifestation marker multivariable analysis multivariable logistic regression Odds ratio Patient performed positive positively correlated receiver operating characteristic ROC ROC analysis sensitivity significantly specificity threshold thrombosis thrombotic VTE with COVID-19 [DOI] 10.1002/ajh.25962 PMC 바로가기 [Article Type] Article
Guidance for the Management of Patients with Vascular Disease or Cardiovascular Risk Factors and COVID-19: Position Paper from VAS-European Independent Foundation in Angiology/Vascular Medicine혈관 질환 또는 심혈관 위험 인자 및 COVID-19가 있는 환자의 관리를 위한 지침: VAS-European Independent Foundation in Angiology/Vascular Medicine의 입장 보고서Review Published on 2020-12-012022-09-12 Journal: Thrombosis and haemostasis [Category] MERS, SARS, 진단, [키워드] advanced age Antithrombotic Antiviral Arterial hypertension cardiovascular cardiovascular disease cardiovascular risk factor Care Community COVID-19 D-dimer Diabetes Mellitus disease disease symptoms eHealth technology Epidemic Factor Follow-up foundation Health high risk hospital discharge Hospitalization hospitalized patient hypercoagulability intermediate dose intravascular coagulation LMWH Male sex management manifested Medicine obesity oral anticoagulant paper Patient physical position progression receive risk risk factor severe COVID-19 Social distancing measure Thromboprophylaxis thrombosis Treatment treatment for COVID-19 unfractionated heparin Vascular vascular disease Venous Thromboembolism VTE VTE risk worsening [DOI] 10.1055/s-0040-1715798 PMC 바로가기 [Article Type] Review
Coagulation parameters and venous thromboembolism in patients with and without COVID-19 admitted to the Emergency Department for acute respiratory insufficiency급성 호흡 부전으로 응급실에 입원한 COVID-19 유무에 관계없이 환자의 응고 매개변수 및 정맥 혈전색전증Observational Study Published on 2020-12-012022-09-11 Journal: Thrombosis research [Category] 바이오마커, 임상, [키워드] Acute respiratory failure Admission Analysis aPTT arterial blood arterial blood gas Asymptomatic Blood blood gas chest CT-scan chest X-ray Coagulation coagulation parameter Coagulation parameters consecutive patient COVID-19 COVID-19 pandemic COVID-19 patient COVID-19 patients COVID19 COVID19 patient COVID19 patients CRP D-dimer D-dimer level D-dimer levels Deep vein Deep vein thrombosis Department diagnosed disease Emergency event ferritin ferritin level ferritin levels Fever fibrinogen fibrinogen level Fibrinogen levels Laboratory tests LDH lower limb lower limbs mean value Multivariate analysis Neutrophils non-COVID-19 patient Non-COVID-19 patients on admission outbreak parameter Patient patients Platelet Platelet count point of care proximal Pulmonary embolism Ratio related disease reported Respiratory failure respiratory insufficiency Retrospective study SARS-CoV 2 significantly higher significantly lower Swab test symptomatic thromboembolic Thromboembolism thrombosis two groups venous thromboembolic Venous Thromboembolism VTE was increased White blood cells [DOI] 10.1016/j.thromres.2020.09.004 PMC 바로가기 [Article Type] Observational Study
Thromboprofilaxys With Fondaparinux vs. Enoxaparin in Hospitalized COVID-19 Patients: A Multicenter Italian Observational StudyMedicine Published on 2020-11-272022-10-31 Journal: Frontiers in Medicine [Category] COVID-19, [키워드] acute respiratory distress acute respiratory distress syndrome anticoagulant therapy bleeding event Clinical characteristics clinical impact Clinical prognosis clinically COVID-19 COVID-19 patient COVID-19 patients cumulative death decreased mortality Deep venous thrombosis drug Effectiveness Efficacy enoxaparin enrolled evaluate event Evidence FIVE Follow-up fondaparinux heparin hospital Hospitalized hospitalized COVID-19 patients hospitalized patient incidence incidence rate interquartile Italian Laboratory major bleeding major bleedings median multicenter observation outcome pharmacological Prophylaxis Prospective Study provide Pulmonary embolism Regression model retrospective risk Safe setting severe coronavirus disease shown significant difference significant differences statistically significant difference symptomatic patient syndrome therapy Thromboprofylaxis Thromboprophylaxis two group Venous Thromboembolism VTE [DOI] 10.3389/fmed.2020.569567 PMC 바로가기 [Article Type] Medicine
Incidence of thromboembolism in patients with COVID-19: a systematic review and meta-analysisResearch Published on 2020-11-232022-10-29 Journal: Thrombosis Journal [Category] COVID-19, [키워드] 95% CI 95% confidence interval arterial thromboembolism calculated coronavirus disease COVID-19 COVID-19 patient diagnosed with COVID-19 DVT Hospitalization hospitalized patient ICU incidence increasingly intensive care Meta-analysis non-ICU setting observational study pandemic Patient prophylactic measure protocol random-effects model reported Result searched significantly higher supplementary material systematic review Thromboembolism thrombosis venous Venous Thromboembolism VTE [DOI] 10.1186/s12959-020-00248-5 PMC 바로가기 [Article Type] Research
Computed tomography characterization and outcome evaluation of COVID-19 pneumonia complicated by venous thromboembolismResearch Article Published on 2020-11-192022-10-28 Journal: PLoS ONE [Category] COVID-19, MERS, SARS, [키워드] adverse outcome affected age analyzed assigned Blood BNP C-reactive protein calculated Care Characteristics Chest CT Cohort Comorbidities conducted consecutive patient correlated COVID-19 CT finding D-dimer death described detect Diagnosis discharge disease ECMO elevated evaluated Evidence extracorporeal membrane oxygenation fibrinogen Follow-up Gender higher risk ICU incidence include intensive care interleukin-6 Laboratory lactate dehydrogenase LDH logistic regression model low-dose majority material mechanical ventilation N-terminal NT-proBNP outcome Patient patients performed Pneumonia positive pro-B-type natriuretic peptide pulmonary angiography Result Retrospective study RT-PCR significantly statistical analysis statistically significant symptom onset Symptoms tertiary care hospital threshold thrombosis tomography transfer Treatment troponine two group Two patient Univariate analysis Venous Thromboembolism VTE was performed [DOI] 10.1371/journal.pone.0242475 PMC 바로가기 [Article Type] Research Article